133 related articles for article (PubMed ID: 9278518)
1. Conditional mutator phenotypes in hMSH2-deficient tumor cell lines.
Richards B; Zhang H; Phear G; Meuth M
Science; 1997 Sep; 277(5331):1523-6. PubMed ID: 9278518
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity.
Risinger JI; Umar A; Boyer JC; Evans AC; Berchuck A; Kunkel TA; Barrett JC
Cancer Res; 1995 Dec; 55(23):5664-9. PubMed ID: 7585651
[TBL] [Abstract][Full Text] [Related]
3. Loss of DNA mismatch repair in acquired resistance to cisplatin.
Aebi S; Kurdi-Haidar B; Gordon R; Cenni B; Zheng H; Fink D; Christen RD; Boland CR; Koi M; Fishel R; Howell SB
Cancer Res; 1996 Jul; 56(13):3087-90. PubMed ID: 8674066
[TBL] [Abstract][Full Text] [Related]
4. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6.
Umar A; Koi M; Risinger JI; Glaab WE; Tindall KR; Kolodner RD; Boland CR; Barrett JC; Kunkel TA
Cancer Res; 1997 Sep; 57(18):3949-55. PubMed ID: 9307278
[TBL] [Abstract][Full Text] [Related]
5. hMLH1 and hMSH2 expression and BAX frameshift mutations in ovarian cancer cell lines and tumors.
Colella G; Vikhanskaya F; Codegoni AM; Bonazzi C; D'Incalci M; Broggini M
Carcinogenesis; 1998 Apr; 19(4):691-4. PubMed ID: 9600357
[TBL] [Abstract][Full Text] [Related]
6. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induced by overexpression of hMSH2 or hMLH1.
Zhang H; Richards B; Wilson T; Lloyd M; Cranston A; Thorburn A; Fishel R; Meuth M
Cancer Res; 1999 Jul; 59(13):3021-7. PubMed ID: 10397236
[TBL] [Abstract][Full Text] [Related]
8. Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects.
Glaab WE; Tindall KR
Carcinogenesis; 1997 Jan; 18(1):1-8. PubMed ID: 9054582
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.
Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A
Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551
[TBL] [Abstract][Full Text] [Related]
10. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
11. Molecular events after antisense inhibition of hMSH2 in a HeLa cell line.
Qian Y; Yu Y; Cheng X; Luo J; Xie H; Shen B
Mutat Res; 1998 Oct; 418(2-3):61-71. PubMed ID: 9756996
[TBL] [Abstract][Full Text] [Related]
12. The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
Leach FS; Velasco A; Hsieh JT; Sagalowsky AI; McConnell JD
J Urol; 2000 Nov; 164(5):1830-3. PubMed ID: 11025778
[TBL] [Abstract][Full Text] [Related]
13. [Expression of mismatch repair gene hMSH2 in human malignant ovarian tumors and its clinical significance].
Ma L; Zhang J; Peng Z
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):291-3. PubMed ID: 11775911
[TBL] [Abstract][Full Text] [Related]
14. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair deficiency in hematological malignancies with microsatellite instability.
Gu L; Cline-Brown B; Zhang F; Qiu L; Li GM
Oncogene; 2002 Aug; 21(37):5758-64. PubMed ID: 12173046
[TBL] [Abstract][Full Text] [Related]
16. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines.
Branch P; Hampson R; Karran P
Cancer Res; 1995 Jun; 55(11):2304-9. PubMed ID: 7757980
[TBL] [Abstract][Full Text] [Related]
17. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.
Leach FS; Polyak K; Burrell M; Johnson KA; Hill D; Dunlop MG; Wyllie AH; Peltomaki P; de la Chapelle A; Hamilton SR; Kinzler KW; Vogelstein B
Cancer Res; 1996 Jan; 56(2):235-40. PubMed ID: 8542572
[TBL] [Abstract][Full Text] [Related]
18. Mismatch repair and microsatellite instability in esophageal cancer cells.
Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
[TBL] [Abstract][Full Text] [Related]
19. Allele loss occurs frequently at hMLH1, but rarely at hMSH2, in sporadic colorectal cancers with microsatellite instability.
Tomlinson IP; Ilyas M; Bodmer WF
Br J Cancer; 1996 Nov; 74(10):1514-7. PubMed ID: 8932328
[TBL] [Abstract][Full Text] [Related]
20. The natural somatic mutation frequency and human carcinogenesis.
Simpson AJ
Adv Cancer Res; 1997; 71():209-40. PubMed ID: 9111867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
